LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0 | 400.00%40K | 0 | -32.50%27K | 0 | -88.46%3K | 100.00%8K | -46.67%16K | 122.22%40K | -211.11%-20K |
Operating revenue | --0 | 400.00%40K | --0 | -32.50%27K | --0 | -88.46%3K | 100.00%8K | -46.67%16K | 122.22%40K | -211.11%-20K |
Cost of revenue | 0 | 433.33%32K | 0 | -30.30%23K | 0 | -96.15%1K | 200.00%6K | -30.43%16K | 312.50%33K | -312.50%-17K |
Gross profit | 0 | 300.00%8K | 0 | -42.86%4K | 0 | 2K | 0.00%2K | 0 | -30.00%7K | -130.00%-3K |
Operating expense | 8.38%2.8M | 14.68%2.77M | -0.29%2.44M | 2.13%9.91M | 2.91%2.47M | 4.79%2.58M | -0.33%2.41M | 1.16%2.44M | -35.25%9.7M | -10.90%2.4M |
Selling and administrative expenses | 24.45%1.58M | 39.27%1.84M | -4.95%1.36M | 2.31%5.19M | 8.79%1.16M | -8.91%1.27M | -3.36%1.32M | 15.56%1.43M | -37.15%5.07M | -22.20%1.07M |
Research and development costs | -4.08%1.5M | -7.88%1.16M | -0.23%1.28M | -4.24%5.56M | -12.11%1.45M | 16.49%1.57M | -6.47%1.26M | -12.34%1.28M | -29.24%5.8M | 12.08%1.65M |
Other operating expenses | -11.67%-287K | -39.64%-236K | 24.91%-202K | 28.67%-836K | 55.52%-141K | 7.22%-257K | 42.52%-169K | 5.28%-269K | 8.79%-1.17M | 71.05%-317K |
Operating profit | -8.46%-2.8M | -14.44%-2.76M | 0.29%-2.44M | -2.17%-9.9M | -2.78%-2.47M | -4.71%-2.58M | 0.33%-2.41M | -1.45%-2.44M | 35.26%-9.69M | 10.45%-2.41M |
Net non-operating interest income expense | -300.00%-4K | 50.00%3K | 50.00%6K | 140.00%12K | 100.00%4K | 100.00%2K | 100.00%2K | 4K | 131.25%5K | 2K |
Non-operating interest income | ---- | 50.00%3K | 50.00%6K | 140.00%12K | ---- | ---- | 100.00%2K | --4K | 66.67%5K | --2K |
Total other finance cost | 300.00%4K | ---- | ---- | ---- | ---- | ---2K | ---- | ---- | ---- | ---- |
Other net income (expense) | 90.38%-43K | -190.03%-343K | 87.72%734K | 178.17%1.39M | -20.83%1.07M | 70.06%-447K | 129.67%381K | 210.45%391K | 16.61%-1.78M | 15,088.89%1.35M |
Gain on sale of security | 90.38%-43K | -190.03%-343K | 87.72%734K | 178.17%1.39M | -20.83%1.07M | 70.06%-447K | 129.67%381K | 210.45%391K | -120.54%-1.78M | 15,088.89%1.35M |
Income before tax | 5.96%-2.84M | -52.84%-3.1M | 17.19%-1.7M | 25.91%-8.5M | -32.77%-1.4M | 23.55%-3.02M | 45.23%-2.03M | 25.85%-2.05M | 33.02%-11.47M | 60.85%-1.06M |
Income tax | 0 | 1K | 0 | 0 | 0 | 0 | 24K | 24K | ||
Net income | 5.96%-2.84M | -52.89%-3.1M | 17.19%-1.7M | 26.06%-8.5M | -29.81%-1.4M | 23.55%-3.02M | 45.23%-2.03M | 25.85%-2.05M | 32.88%-11.5M | 59.96%-1.08M |
Net income continuous Operations | 5.96%-2.84M | -52.89%-3.1M | 17.19%-1.7M | 26.06%-8.5M | -29.81%-1.4M | 23.55%-3.02M | 45.23%-2.03M | 25.85%-2.05M | 32.88%-11.5M | 59.96%-1.08M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 5.96%-2.84M | -52.89%-3.1M | 17.19%-1.7M | 26.06%-8.5M | -29.81%-1.4M | 23.55%-3.02M | 45.23%-2.03M | 25.85%-2.05M | 32.88%-11.5M | 59.96%-1.08M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 5.96%-2.84M | -52.89%-3.1M | 17.19%-1.7M | 26.06%-8.5M | -29.81%-1.4M | 23.55%-3.02M | 45.23%-2.03M | 25.85%-2.05M | 32.88%-11.5M | 59.96%-1.08M |
Basic earnings per share | 51.69%-0.86 | 46.15%-0.98 | 74.69%-0.62 | 54.47%-6.32 | 60.63%-0.5 | 62.53%-1.78 | 60.00%-1.82 | 30.00%-2.45 | 41.68%-13.88 | 59.68%-1.27 |
Diluted earnings per share | 51.69%-0.86 | 46.15%-0.98 | -31.02%-3.21 | 54.47%-6.32 | 60.63%-0.5 | 62.53%-1.78 | 60.00%-1.82 | 30.00%-2.45 | 41.68%-13.88 | 59.68%-1.27 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |